✦ LIBER ✦

L-acetylcarnitine and Alzheimer's disease: Results of a controlled clinical trial

✍ Scribed by Yu, Juhyon; Guo, Mingyi; Muhammad, Faheem; Wang, Aifei; Zhang, Feng; Li, Qin; Zhu, Guangshan

Book ID: 122582692
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 286 KB
Volume: 11
Category: Article
ISSN: 0197-4580
DOI: 10.1016/0197-4580(90)90923-N

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Medical nutrition in Alzheimer's disease

Medical nutrition in Alzheimer's disease: First results and clinical trial

✍ P. Scheltens 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Neurotrophic and cholinergic treatment i

Neurotrophic and cholinergic treatment in Alzheimer's disease: Results of a randomized clinical trial

✍ Alvarez, Anton; Sampedro, Carolina; Couceiro, Veronica; Cacabelos, Ramon; Aleixa 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Alzheimer’s disease multiple interventio

Alzheimer’s disease multiple intervention trial (ADMIT): study protocol for a randomized controlled clinical trial

✍ Christopher M Callahan, Malaz A Boustani, Arlene A Schmid, Mary G Austrom, Dougl 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 270 KB

Results of a recent treatment trial in A

Results of a recent treatment trial in Alzheimer's disease

✍ Ruth A. Mulnard 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Results of a randomized, placebo-control

Results of a randomized, placebo-controlled clinical trial of famvir for active Meniere’s disease

✍ M.Jennifer Derebery; Laurel M. Fisher; Ann Masuda 📂 Article 📅 2003 🏛 SAGE Publications 🌐 English ⚖ 48 KB

Risperidone for psychosis of Alzheimer's

Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial

✍ Henry Brodaty; David Ames; John Snowdon; Michael Woodward; Jeff Kirwan; Roger Cl 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Objective: To evaluate the efficacy and safety of low-dose risperidone in treating psychosis of alzheimer's disease (ad) and mixed dementia (md) in a subset of nursing-home residents who had dementia and aggression and who were participating in a randomized placebo-controlled trial of risperidon